NAD+ grades: powder, granulate and the oxidation state
There is one catalog chemical grade of β-NAD, two physical presentations and one lookalike material that is often mistaken for a grade. The grade is β-nicotinamide adenine dinucleotide, CAS 53-84-9, with an assay of ≥95.0% by HPLC; the presentations are powder and granulate; the lookalike is NADH, CAS 606-68-8, the reduced oxidation state. An order that names only “NAD” has not chosen among them.
The grade is the form plus the presentation: NAD+ or NADH decides the chemistry, and powder or granulate decides how it flows, not what it is.
One grade, two packs, one lookalike
Start with the oxidation state, because it is the choice that changes the molecule. NAD+ is oxidised; NADH is reduced. They carry different CAS numbers, different UV behaviour and different stability risks. NADH is not a higher grade of NAD+ and cannot be used gram for gram in its place. The level-four comparison sets out the chemistry.
Within the oxidised form, the catalog has one assay specification. Powder and granulate share it. Granulation changes particle size, flow and dust; it does not change identity or assay. A granulated lot is a legitimate production variant, but it is a specification change with its own particle-size line.
The catalog powder, a granulate and NADH
Three columns, two questions. The first two answer “which pack?”; the third answers “which molecule?”.
| Property | β-NAD powder (catalog) | β-NAD granulated | NADH |
|---|---|---|---|
| CAS number | 53-84-9 | 53-84-9 | 606-68-8 |
| Oxidation state | Oxidised | Oxidised | Reduced |
| Assay | ≥95.0% by HPLC | Same assay limit | Separate method and limit |
| Water | ≤5.0% by Karl Fischer | Same water limit | Separate limit |
| pH (1% solution) | 2.0–4.0 | Same pH limit | Separate limit |
| Particle and flow | Fine powder | Larger particles, freer flow | Not a β-NAD presentation |
| Typical format | Capsules, sticks, mixes | High-speed filling, dust control | Separate project |
Read the third column as a different product. Its certificate carries its own method and limits; the β-NAD numbers do not transfer. A quotation that lists “NAD” and “NADH” without CAS numbers has not settled the molecule.
Powder, water and the granulate
The catalog powder is white to off-white and dissolves freely in water to an acidic solution. It is hygroscopic: exposed to humid air it gains water, the Karl Fischer figure rises and the as-is assay falls. Heat speeds the damage, and keeping it in solution is the least durable option.
Granulation buys flow and less dust. It does not buy moisture protection. A granulate still needs a sealed pack, and it needs a particle-size specification and a dispersion check that the powder specification does not contain.
Which presentation fits the dosage form
A capsule or tablet takes the powder as supplied. A granulate feeds more easily on a high-speed press and keeps the filling room cleaner. A stick or drink mix uses the powder because it dissolves, but the drink introduces water at the start; the formulator has to validate pH, heat load and hold time.
The weigh-up depends on the assay basis. At 95.0% as-is, 100 mg declared needs 105.3 mg of powder. If the assay is anhydrous, restore the water first. Declared mass, assay basis and water belong on the same batch-record line.
Specification text for β-NAD
Write it so that two laboratories would report the same numbers:
- “β-Nicotinamide adenine dinucleotide (NAD+), CAS 53-84-9, C21H27N7O14P2, molecular weight 663.43.”
- “Assay ≥95.0% by HPLC; state as-is or anhydrous, and name the detection wavelength.”
- “Water ≤5.0% by Karl Fischer; pH 2.0–4.0 in a 1% solution.”
- “White to off-white powder; identification by HPLC retention and UV spectrum.”
- “Heavy metals and microbiology as listed; each element reported separately.”
- “Presentation: powder or granulated; the granulate carries its own particle-size line.”
- “Oxidation state, destination market and finished-product form confirmed before the order.”
We supply β-NAD powder; granulate is quoted on request. NADH is a separate purchase with its own assay, certificate and label, and it should not replace NAD+ without written change control.
Where the choice goes wrong
Granulate is the wrong choice for a bench trial that needs a fine, fast-dispersing powder, and it is the wrong choice when the filling line has not been qualified for larger particles. NADH is the wrong choice whenever the label, the specification or the market file names the oxidised form.
Equally, a project built around NADH should not accept β-NAD as “close enough” and correct the dose later. The oxidation state is part of the identity.
NAD+ is also not NMN or nicotinamide riboside: those are different molecules with their own specifications, and the NMN page and the nicotinamide riboside page describe them separately. The product hub holds the catalog values; the COA page records the form at release; the stability page covers the pack and the solution; the quality page describes the release file.
In this document
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation